Back
NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
37
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
1.9%
7 Day Trial
ALL ACCESS PASS
$
7
NovaBay Pharmaceuticals Price Quote
$0.12
+0.02 (+14.83%)
(Updated: May 16, 2024 at 6:55 PM ET)
NovaBay Pharmaceuticals Key Stats
Sell
37
NovaBay Pharmaceuticals (NBY)
is a Sell
Day range:
$0.09 - $0.11
52-week range:
$0.07 - $1.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.08
P/B ratio:
0%
Volume:
10.8M
Avg. volume:
2.8M
1-year change:
-86.38%
Market cap:
$4M
Revenue:
$14.7M
EPS:
$-2.61
How Much Does NovaBay Pharmaceuticals Make?
-
How Much Are NovaBay Pharmaceuticals's Sales Annually?
NBY Revenues are $14.7M -
How Much Profit Does NovaBay Pharmaceuticals's Make A Year?
NBY net income is -$9.6M
Is NovaBay Pharmaceuticals Growing As A Company?
-
What Is NovaBay Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.12% -
What Is NovaBay Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
NovaBay Pharmaceuticals Stock Price Performance
-
Did NovaBay Pharmaceuticals Stock Go Up Last Month?
NovaBay Pharmaceuticals share price went up by 28.22% last month -
Did NBY's Share Price Rise Over The Last Year?
NBY share price fell by -86.38% over the past 1 year
What Is NovaBay Pharmaceuticals 52-Week High & Low?
-
What Is NovaBay Pharmaceuticals’s 52-Week High Share Price?
NovaBay Pharmaceuticals has traded as high as $1.28 over the past 52 weeks -
What Is NovaBay Pharmaceuticals’s 52-Week Low Share Price?
NovaBay Pharmaceuticals has traded as low as $0.07 over the past 52 weeks
NovaBay Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NovaBay Pharmaceuticals?
-
How Much Debt Does NovaBay Pharmaceuticals Have?
Total long term debt quarterly is $1M -
How Much Cash Does NovaBay Pharmaceuticals Have?
Cash and short term investments quarterly total is $1.8M -
What Is NovaBay Pharmaceuticals’s Book Value Per Share?
Book value per share is -0.04
Is NovaBay Pharmaceuticals Cash Flow Positive?
-
What Is NBY Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.5M -
What Is NovaBay Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.3M -
What Is NovaBay Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.1M
NovaBay Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
NBY return on invested capital is -170.67% -
What Is NovaBay Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -95.69% -
What Is NBY Return On Equity?
ROE is a measure of profitability and is -198.74%
NovaBay Pharmaceuticals Earnings Date & Stock Price
-
What Is NovaBay Pharmaceuticals's Stock Price Today?
A single share of NBY can be purchased today for 0.10 -
What Is NovaBay Pharmaceuticals’s Stock Symbol?
NovaBay Pharmaceuticals trades on the nyam under the ticker symbol: NBY -
When Is NovaBay Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NovaBay Pharmaceuticals is scheduled on May 17, 2024 -
When Is NBY's next ex-dividend date?
NovaBay Pharmaceuticals's next ex-dividend date is May 17, 2024 -
How To Buy NovaBay Pharmaceuticals Stock?
You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NovaBay Pharmaceuticals Competitors
-
Who Are NovaBay Pharmaceuticals's Competitors?
Below is a list of companies who compete with NovaBay Pharmaceuticals or are related in some way:
NovaBay Pharmaceuticals Dividend Yield
Data Unavailable
NovaBay Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.8% |
| Revenue: | 12.48% | -19.79% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 2.60 |
| Upside from Last Price: | 2388.04% |